On Monday, nearly 1,200 new COVID-19 cases and two confirmed deaths caused by the disease were reported in New Jersey. While scientists are also turning their attention to the lucky — and rare — individuals who have managed to dodge the coronavirus for more than two...
Nearly a year after many rich nations achieved widespread vaccination against COVID-19, many less affluent countries still face difficult choices about which groups of people should be the first to receive vaccines from a limited supply. Most of these nations appear...
Researcher Workbench expands participant data to drive unique insights Health data from nearly 20,000 people who have had SARS-CoV-2 is now available to researchers across the U.S., opening new opportunities to study COVID-19 disease prevention, progression, and...
It’s the most infectious strain yet, coming even as many people have written off the pandemic. BA.5, now the dominant coronavirus subvariant in New Jersey and the U.S., has shown resistance to COVID-19 vaccines, making experts nervous. Worse, prior immunity doesn’t...
Researchers from Rutgers, the University of South Florida and Catholic University of America, whose work has yet to undergo peer review, identified 66 prevalent Mpro mutations located at the nirmatrelvir binding site, where Paxlovid attaches itself to the virus. Many...
